情态动词
背景(考古学)
计算机科学
人工智能
眼底(子宫)
机器学习
模态(人机交互)
学习迁移
模式识别(心理学)
医学
放射科
古生物学
化学
高分子化学
生物
作者
Ruhan Liu,Tianqin Wang,Huating Li,Ping Zhang,Jing Li,Xiaokang Yang,Dinggang Shen,Bin Sheng
出处
期刊:IEEE Transactions on Medical Imaging
[Institute of Electrical and Electronics Engineers]
日期:2022-11-21
卷期号:42 (4): 1083-1094
被引量:10
标识
DOI:10.1109/tmi.2022.3223683
摘要
Rare diseases, which are severely underrepresented in basic and clinical research, can particularly benefit from machine learning techniques. However, current learning-based approaches usually focus on either mono-modal image data or matched multi-modal data, whereas the diagnosis of rare diseases necessitates the aggregation of unstructured and unmatched multi-modal image data due to their rare and diverse nature. In this study, we therefore propose diagnosis-guided multi-to-mono modal generation networks (TMM-Nets) along with training and testing procedures. TMM-Nets can transfer data from multiple sources to a single modality for diagnostic data structurization. To demonstrate their potential in the context of rare diseases, TMM-Nets were deployed to diagnose the lupus retinopathy (LR-SLE), leveraging unmatched regular and ultra-wide-field fundus images for transfer learning. The TMM-Nets encoded the transfer learning from diabetic retinopathy to LR-SLE based on the similarity of the fundus lesions. In addition, a lesion-aware multi-scale attention mechanism was developed for clinical alerts, enabling TMM-Nets not only to inform patient care, but also to provide insights consistent with those of clinicians. An adversarial strategy was also developed to refine multi- to mono-modal image generation based on diagnostic results and the data distribution to enhance the data augmentation performance. Compared to the baseline model, the TMM-Nets showed 35.19% and 33.56% F1 score improvements on the test and external validation sets, respectively. In addition, the TMM-Nets can be used to develop diagnostic models for other rare diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI